These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 31207390)

  • 1. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease.
    Mendonça CF; Kuras M; Nogueira FCS; Plá I; Hortobágyi T; Csiba L; Palkovits M; Renner É; Döme P; Marko-Varga G; Domont GB; Rezeli M
    Neurobiol Dis; 2019 Oct; 130():104509. PubMed ID: 31207390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topological Dissection of Proteomic Changes Linked to the Limbic Stage of Alzheimer's Disease.
    Velásquez E; Szeitz B; Gil J; Rodriguez J; Palkovits M; Renner É; Hortobágyi T; Döme P; Nogueira FC; Marko-Varga G; Domont GB; Rezeli M
    Front Immunol; 2021; 12():750665. PubMed ID: 34712240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging.
    Maass A; Lockhart SN; Harrison TM; Bell RK; Mellinger T; Swinnerton K; Baker SL; Rabinovici GD; Jagust WJ
    J Neurosci; 2018 Jan; 38(3):530-543. PubMed ID: 29192126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities.
    de Flores R; Das SR; Xie L; Wisse LEM; Lyu X; Shah P; Yushkevich PA; Wolk DA
    J Neurosci; 2022 Mar; 42(10):2131-2141. PubMed ID: 35086906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis identifies HSP90AA1, PTK2B, and ANXA2 in the human entorhinal cortex in Alzheimer's disease: Potential role in synaptic homeostasis and Aβ pathology through microglial and astroglial cells.
    Astillero-Lopez V; Villar-Conde S; Gonzalez-Rodriguez M; Flores-Cuadrado A; Ubeda-Banon I; Saiz-Sanchez D; Martinez-Marcos A
    Brain Pathol; 2024 Jul; 34(4):e13235. PubMed ID: 38247340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic changes in Alzheimer's disease associated with progressive Aβ plaque and tau tangle pathologies.
    Pichet Binette A; Gaiteri C; Wennström M; Kumar A; Hristovska I; Spotorno N; Salvadó G; Strandberg O; Mathys H; Tsai LH; Palmqvist S; Mattsson-Carlgren N; Janelidze S; Stomrud E; Vogel JW; Hansson O
    Nat Neurosci; 2024 Oct; 27(10):1880-1891. PubMed ID: 39187705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of different tau sites during progression of Alzheimer's disease.
    Neddens J; Temmel M; Flunkert S; Kerschbaumer B; Hoeller C; Loeffler T; Niederkofler V; Daum G; Attems J; Hutter-Paier B
    Acta Neuropathol Commun; 2018 Jun; 6(1):52. PubMed ID: 29958544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
    Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
    Merlini M; Wanner D; Nitsch RM
    Acta Neuropathol; 2016 May; 131(5):737-52. PubMed ID: 26988843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional mosaic genomic heterogeneity in the elderly and in Alzheimer's disease as a correlate of neuronal vulnerability.
    Arendt T; Brückner MK; Lösche A
    Acta Neuropathol; 2015 Oct; 130(4):501-10. PubMed ID: 26298468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain.
    Ercan-Herbst E; Ehrig J; Schöndorf DC; Behrendt A; Klaus B; Gomez Ramos B; Prat Oriol N; Weber C; Ehrnhoefer DE
    Acta Neuropathol Commun; 2019 Dec; 7(1):192. PubMed ID: 31796124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology.
    Stratmann K; Heinsen H; Korf HW; Del Turco D; Ghebremedhin E; Seidel K; Bouzrou M; Grinberg LT; Bohl J; Wharton SB; den Dunnen W; Rüb U
    Brain Pathol; 2016 May; 26(3):371-86. PubMed ID: 26193084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease.
    Ferrer I; Andrés-Benito P; Ausín K; Pamplona R; Del Rio JA; Fernández-Irigoyen J; Santamaría E
    Brain Pathol; 2021 Nov; 31(6):e12996. PubMed ID: 34218486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
    Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome.
    Davidson YS; Robinson A; Prasher VP; Mann DMA
    Acta Neuropathol Commun; 2018 Jul; 6(1):56. PubMed ID: 29973279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-enriched plasma proteome is significantly altered in Alzheimer's disease.
    Guo Q; Ping L; Dammer EB; Duong DM; Yin L; Xu K; Shantaraman A; Fox EJ; Golde TE; Johnson ECB; Roberts BR; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2024 Oct; 19(1):67. PubMed ID: 39380021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.